Glomerular Disease in 2018: Where Are We Now, and Where Are We Going?

Glomerular Disease in 2018: Where Are We Now, and Where Are We Going? is organized by National Kidney Foundation (NKF).

Course Opens: 08/22/2018
Course Expires: 08/22/2020

Target Audience: 
• Physicians 
• Physician Assistants 
• Nurse Practitioners

Available Credit:
• 2.00 AMA PRA Category 1 Credit™
• 2.00 ANCC Nurse Contact Hours
• 0.92 ANCC Pharmacology
• 2.00 Attendance
• 2.00 Category I Credit for Physician Assistants

Description:
This activity will use case-based learning to highlight three important and complex glomerular diseases: membranous nephropathy, ANCA associated vasculitis and paraprotein-associated kidney disease. The presenters are experts who will review how recent advances have changed the paradigm of approaching these diseases, and how future research could revolutionize the way they are managed. Participants will gain an understanding of the use of biomarkers and novel, targeted therapies in these disorders.

Learning Objectives:
After participation in this activity, learners will be better able to:
• Explain the approaches to the diagnosis of ANCA associated vasculitis, membranous nephropathy, and paraprotein-associated kidney disease
• Describe first-line therapies for ANCA associated vasculitis, membranous nephropathy, and paraprotein-associated kidney disease
• Recognize how current studies could impact the diagnosis and treatment of these disorders

Additional details will be posted as soon as they are available.